Pseudoparticle neutralization assay for detecting ebola- neutralizing antibodies in biosafety level 2 settings

Affiliations

¹ Centre of Influenza Research School of Public Health and.
² Department of Pathobiological Sciences School of Veterinary Medicine University of Wisconsin Madison, WI.
³ Department of Pathobiological Sciences School of Veterinary Medicine University of Wisconsin Madison, WI Division of Virology Department of Microbiology and Immunology Institute of Medical Science University of Tokyo, Tokyo, Japan.
⁴ Centre of Influenza Research School of Public Health and HKU-Pasteur Pole The University of Hong Kong Hong Kong, China.
⁵ Centre of Influenza Research School of Public Health and llmpoon@hku.hk.

Alex W H Chin et al. Clin Chem. 2015 Jun.

. 2015 Jun;61(6):885-6.

doi: 10.1373/clinchem.2015.238204. Epub 2015 Mar 31.

¹ Centre of Influenza Research School of Public Health and.
² Department of Pathobiological Sciences School of Veterinary Medicine University of Wisconsin Madison, WI.
³ Department of Pathobiological Sciences School of Veterinary Medicine University of Wisconsin Madison, WI Division of Virology Department of Microbiology and Immunology Institute of Medical Science University of Tokyo, Tokyo, Japan.
⁴ Centre of Influenza Research School of Public Health and HKU-Pasteur Pole The University of Hong Kong Hong Kong, China.
⁵ Centre of Influenza Research School of Public Health and llmpoon@hku.hk.

No abstract available

References

1. WHO. Laboratory guidance of Ebola virus disease. http://www.who.int/csr/resources/publications/ebola/laboratory-guidance/en/ (Accessed May 2015).
1. Baize S, Pannetier D, Oestereich L, Rieger T, Koivogui L, Magassouba N, et al. Emergence of Zaire Ebola virus disease in Guinea. N Engl J Med 2014;371:1418–25. - PubMed
1. Garcia JM, Pepin S, Lagarde N, Ma ES, Vogel FR, Chan KH, et al. Heterosubtype neutralizing responses to influenza A (H5N1) viruses are mediated by antibodies to virus haemagglutinin. PLoS One 2009;4:e7918. - PMC - PubMed
1. Perera RA, Wang P, Gomaa MR, El-Shesheny R, Kandeil A, Bagato O, et al. Seroepidemiology for MERS coronavirus using microneutralisation and pseudoparticle virus neutralisation assays reveal a high prevalence of antibody in dromedary camels in Egypt, June 2013. Euro Surveill 2013;18:pii=20574. - PubMed
1. Takada A, Feldmann H, Stroeher U, Bray M, Watanabe S, Ito H, et al. Identification of protective epitopes on Ebola virus glycoprotein at the single amino acid level by using recombinant vesicular stomatitis viruses. J Virol 2003;77:1069–74. - PMC - PubMed